AR077431A1 - DERIVADOS DE PIPERIDINA, PROCESOS DE PREPARACIoN Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENE. - Google Patents
DERIVADOS DE PIPERIDINA, PROCESOS DE PREPARACIoN Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENE.Info
- Publication number
- AR077431A1 AR077431A1 ARP100102729A ARP100102729A AR077431A1 AR 077431 A1 AR077431 A1 AR 077431A1 AR P100102729 A ARP100102729 A AR P100102729A AR P100102729 A ARP100102729 A AR P100102729A AR 077431 A1 AR077431 A1 AR 077431A1
- Authority
- AR
- Argentina
- Prior art keywords
- substituted
- phenyl
- cycloalkyl
- alkyl
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Los compuestos de la formula 1 así como las sales farmacéuticamente aceptables de los mismos pueden utilizarse como composiciones farmacéuticas. Reivindicacion 1. Compuesto de la formula (1) en la que R1 es alquilo, cicloalquilo, cicloalquilalquilo, haloalquilo, tiofenilo, tiofenilo sustituido, fenilo, fenilo sustituido, benciloxi, benciloxi sustituido, piridinilo, piridinilo sustituido, pirimidilo o pirimidilo sustituido, dichos tiofenilo sustituido, fenilo sustituido, benciloxi sustituido, piridinilo sustituido y pirimidilo sustituido están sustituidos de una a tres veces por sustituyentes elegidos con independencia entre alquilo, cicloalquilo, halogeno, hidroxi, alcoxi, cicloalquilalcoxi, haloalquilo, haloalcoxi, alquilsulfonilo y cicloalquilsulfonilo; R2 es hidrogeno, alquilo o cicloalquilo; R3 es indanilo, indanilo sustituido, piridinilo, piridinilo sustituido, pirimidilo, pirimidilo sustituido, fenilo o fenilo sustituido, dichos indanilo sustituido, piridinilo sustituido y pirimidilo sustituido están sustituidos de una a tres veces por sustituyentes elegidos con independencia entre alquilo, cicloalquilo, halogeno, hidroxi, alcoxi, cicloalquilalcoxi, haloalquilo, haloalcoxi y alquenilo, y dicho fenilo sustituido es fenilo sustituido por un sustituyente elegido entre alquilo, cicloalquilo, halogeno, hidroxi, alcoxi, cicloalquilalcoxi, haloalquilo, haloalcoxi y alquenilo; R4 es hidrogeno, alquilo o cicloalquilo; uno de R5 y R6 es hidrogeno, alquilo o cicloalquilo y el otro es hidrogeno, alquilo, cicloalquilo, fenilo o fenilo sustituido, dicho fenilo sustituido es fenilo sustituido de una a tres veces por sustituyentes elegidos con independencia entre alquilo, cicloalquilo, halogeno, hidroxi, alcoxi, cicloalquilalcoxi, haloalquilo, haloalcoxi, alquilsulfonilo y cicloalquilsulfonilo; R7 es hidrogeno, alquilo o cicloalquilo, pero en el caso de que R1 sea benciloxi, entonces tanto R2 como R7: son hidrogeno; A1 es carbonilo, -S(O)2-, -NHC(O)- o -CR5R6-; A2 es -O- o -NR7-; y las sales farmacéuticamente aceptables de los mismos; con la condicion de que se excluyan la (3-trifluormetil-fenil)-amida del ácido 1-bencil-4-dimetilamino-piperidina-4-carboxílico y la fenilamida del ácido 4-dimetilamino-l-isopropil-piperidina-4-carboxílico.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09166846 | 2009-07-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR077431A1 true AR077431A1 (es) | 2011-08-24 |
Family
ID=42938635
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP100102729A AR077431A1 (es) | 2009-07-30 | 2010-07-28 | DERIVADOS DE PIPERIDINA, PROCESOS DE PREPARACIoN Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENE. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8399676B2 (es) |
| EP (1) | EP2480532B1 (es) |
| JP (1) | JP5503000B2 (es) |
| KR (1) | KR101359875B1 (es) |
| CN (1) | CN102471265B (es) |
| AR (1) | AR077431A1 (es) |
| AU (1) | AU2010277622A1 (es) |
| BR (1) | BR112012002133A2 (es) |
| CA (1) | CA2766886A1 (es) |
| ES (1) | ES2439797T3 (es) |
| IL (1) | IL216738A0 (es) |
| MX (1) | MX2012001229A (es) |
| SG (1) | SG178128A1 (es) |
| TW (1) | TW201107290A (es) |
| WO (1) | WO2011012602A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8258158B2 (en) * | 2009-09-11 | 2012-09-04 | Hoffmann-La Roche Inc. | HSL inhibitors useful in the treatment of diabetes |
| US20230303552A1 (en) * | 2020-06-19 | 2023-09-28 | Vanderbilt University | Arylsulfonyl derivatives and their use as muscarinic acetylcholine receptor m5 inhibitors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK139684A (da) | 1983-04-11 | 1984-10-12 | Janssen Pharmaceutica Nv | N-aryl-alpha-amino-carboxamider |
| KR860001904B1 (ko) * | 1983-04-11 | 1986-10-24 | 쟈안센 파아마슈우티카 엔·부이· | N-아릴-α-아미노-카복스아미드의 제조방법 |
| EP2038255A2 (en) * | 2006-06-16 | 2009-03-25 | High Point Pharmaceuticals, LLC | Pharmaceutical use of substituted piperidine carboxamides |
| US20080227823A1 (en) | 2007-03-12 | 2008-09-18 | Hassan Pajouhesh | Amide derivatives as calcium channel blockers |
| US8324250B2 (en) * | 2009-03-19 | 2012-12-04 | Hoffmann-La Roche Inc. | Piperidine derivatives as NK3 receptor antagonists |
-
2010
- 2010-07-23 US US12/842,062 patent/US8399676B2/en not_active Expired - Fee Related
- 2010-07-27 BR BR112012002133A patent/BR112012002133A2/pt not_active IP Right Cessation
- 2010-07-27 CN CN201080033807.5A patent/CN102471265B/zh not_active Expired - Fee Related
- 2010-07-27 TW TW099124761A patent/TW201107290A/zh unknown
- 2010-07-27 ES ES10739338.1T patent/ES2439797T3/es active Active
- 2010-07-27 SG SG2012005906A patent/SG178128A1/en unknown
- 2010-07-27 WO PCT/EP2010/060854 patent/WO2011012602A1/en active Application Filing
- 2010-07-27 CA CA2766886A patent/CA2766886A1/en not_active Abandoned
- 2010-07-27 MX MX2012001229A patent/MX2012001229A/es active IP Right Grant
- 2010-07-27 KR KR1020127004384A patent/KR101359875B1/ko not_active IP Right Cessation
- 2010-07-27 EP EP10739338.1A patent/EP2480532B1/en not_active Not-in-force
- 2010-07-27 JP JP2012521058A patent/JP5503000B2/ja not_active Expired - Fee Related
- 2010-07-27 AU AU2010277622A patent/AU2010277622A1/en not_active Abandoned
- 2010-07-28 AR ARP100102729A patent/AR077431A1/es unknown
-
2011
- 2011-12-01 IL IL216738A patent/IL216738A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011012602A1 (en) | 2011-02-03 |
| TW201107290A (en) | 2011-03-01 |
| EP2480532B1 (en) | 2013-11-20 |
| US8399676B2 (en) | 2013-03-19 |
| KR101359875B1 (ko) | 2014-02-06 |
| US20110028515A1 (en) | 2011-02-03 |
| AU2010277622A1 (en) | 2012-02-02 |
| IL216738A0 (en) | 2012-02-29 |
| KR20120034805A (ko) | 2012-04-12 |
| JP2012533606A (ja) | 2012-12-27 |
| JP5503000B2 (ja) | 2014-05-28 |
| CN102471265B (zh) | 2014-09-03 |
| CN102471265A (zh) | 2012-05-23 |
| ES2439797T3 (es) | 2014-01-24 |
| MX2012001229A (es) | 2012-03-16 |
| SG178128A1 (en) | 2012-03-29 |
| BR112012002133A2 (pt) | 2019-09-24 |
| EP2480532A1 (en) | 2012-08-01 |
| CA2766886A1 (en) | 2011-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2521596T3 (es) | Combinación del compuesto GlyT1 con antipsicóticos | |
| ES2640911T3 (es) | Cicloalquilnitrilpirazolcarboxamidas como inhibidores de la quinasa Janus | |
| AR065322A1 (es) | 2-aminooxazolinas comoligandos de taar1 | |
| AR076435A1 (es) | Compuestos de indazoles sustituidos, composiciones farmaceuticas que los contienen y procesos de obtencion de los mismos | |
| AR073136A1 (es) | Compuestos de pirrol | |
| AR052568A1 (es) | Derivados de pirazolo -pirimidina como antagonstas de mglur2 | |
| AR066107A1 (es) | Derivados de triazolopiridin - carboxamidas y triazolopirimidin-carboxamidas, su preparacion y su aplicacion en terapeutica como inhibidores de la enzimamonoacil glicerol lipasa y composiciones qu los contienen. | |
| AR082004A1 (es) | Compuestos de fusion de piridina | |
| ES2653265T3 (es) | Morfinanos sustituidos y el uso de éstos | |
| UY31260A1 (es) | Compuestos de pirazol, composiciones conteniendolos y aplicaciones. | |
| AR086590A1 (es) | Compuestos de ciclohexanona y herbicidas que los comprenden | |
| AR082111A1 (es) | Furopiridinas o tienopiridinas condensadas, composiciones farmaceuticas que las contienen utiles para tratar trastornos psicoticos y del sistema nervioso central, y metodo de preparacion de las mismas | |
| AR091519A1 (es) | Inhibidores pirrolopirazona de tanquirasa | |
| AR050266A1 (es) | Derivados de bencil-triazolona como inhibidores no nucleosidos de transcriptasa inversa | |
| AR087311A1 (es) | Quinolinas sustituidas y su uso como medicamentos | |
| AR059513A1 (es) | Derivados benzoil - piperidina como moduladores de 5ht/ d3 | |
| AR084011A1 (es) | Compuestos nitrogenados heterociclicos utiles para el tratamiento de infecciones por el virus sincitial respiratorio (rsv), proceso para prepararlos y composiciones farmaceuticas que los contienen | |
| ECSP088731A (es) | Derivados de 1,2,4,5-tetrahidro-3h-benzazepinas, su procedimiento de preparación y las composiciones farmacéuticas que las contienen | |
| AR073565A1 (es) | Derivados de bencimidazol, procesos de preparacion y composiciones farmaceuticas que los contienen | |
| AR101359A1 (es) | Derivados de 2-oxa-5-azabiciclo[2.2.1]heptan-3-ilo | |
| AR066605A1 (es) | Derivados de heteroarilamida pirimidona | |
| CO6400145A2 (es) | Derivados de 2-piridin-2-il pirazol-3(2h) -ona, su preparción y su aplicación terapeútica | |
| CR20130476A (es) | Derivados de pirazolidin-3-ona | |
| AR065904A1 (es) | Heterociclos como antagonistas de orexina | |
| AR054072A1 (es) | 3-amino arilpropil indoles como inhibidores de reabsorcion de monoaminas. procesos de obtencion y composiciones farmaceuticas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |